JPMorgan Chase & Co.

▲ Bull Case

• ◆ROTCE structural floor at 19-21%: JPM's $17B+ annual tech spend, compliance scale, and #1 IB wallet create durable structural advantages that peers (BAC 14-15%, WFC 13-14%, C 8-9%) cannot bridge. Through-cycle ROTCE of 21%+ justifies P/TBV 2.8-3.0x and EPS of $25-28 in FY2027.
• ◆CIB + AWM compounding: The IB super-cycle (M&A rebound, rate volatility, equity issuance) and AWM's $7.1T AUM growing with wealth transfer tailwind generate fee income diversification. Non-NII growing to $96-100B by FY2027E creates earnings floor even in rate-cut environments.
• ◆Orderly succession = Dimon premium preserved: Lake → CEO + Dimon → Executive Chairman removes the key idiosyncratic risk in a known, planned structure. Institutional continuity is preserved. Market should re-rate succession discount out in early 2027.

▼ Bear Case

• ◆NII roll-down risk: Fed rate cuts compress NII by $1-2B per 25bp cut. A 200bp cutting cycle reduces NII from $103B to $87-95B, a $8-16B annual headwind. At 35% net margin, this is a $5-10B hit to net income, erasing 1-2 years of compounding.
• ◆Credit cycle normalization → provision spike: Card NCO rate guided at 3.4% but could reach 4.5-5.5% in a consumer downturn. A 1pp NCO increase adds ~$2B provision expense. Combined with NII compression in a rate-cut cycle, both headwinds arrive simultaneously.
• ◆Stock fully priced: P/TBV 2.56x at current prices leaves no margin of safety on the base case (fair value ~$266-285). A compression from 2.56x to 2.2x P/TBV (justified if ROTCE normalizes to 17-18%) translates to ~$255/share, 14% below current.

“Central debate: Is JPM's 19-23% ROTCE structural or cyclical? Bull view: JPM's scale ($17B tech, $4.4T assets), CIB wallet dominance, and AWM AUM growth are permanent structural advantages flooring ROTCE at 19%+ regardless of rate environment. Stock deserves 13-15x P/E similar to Morgan Stanley. Bear view: FY2024-2026 ROTCE peak was turbo-charged by 2022-2024 rate windfall (NII exploded from $60B to $95B). As Fed cuts, NII normalizes, loan growth slows, and through-cycle ROTCE reverts to Dimon's 17% floor. P/TBV should compress to 2.0-2.2x → $232-255/share. Consensus prices 21% sustained ROTCE at 2.56x P/TBV (PT ~$320-330). Debate will be resolved by Q3-Q4 2026 NII and NCO data.”

• ◆Q2 2026 earnings (July 2026): NII trajectory vs. $103B guidance; signal NII ≥$24.5B/qtr = bull intact, <$23B = bear case triggered
• ◆CCAR/DFAST 2026 (Summer 2026): Stress capital buffer determines buyback authorization; <9% SCB = more buybacks authorized, >10.5% = capital constraint
• ◆Lake → CEO transition (January 1, 2027): Orderly succession = succession discount lifted; any Lake/Erdoes/Piepszak departure = negative re-rating
• ◆Basel III endgame final rule (H2 2026): Softened capital surcharge = buyback acceleration; harsh surcharge >150bp = capital drain and P/TBV compression
• ◆Fed rate decisions (2H 2026): Pause = NII stable; 2+ cuts = NII $100-101B; 4+ cuts = bear thesis setup
• ◆M&A market continuity (rolling quarterly): CIB IB fees >$3B/qtr = super-cycle persists; <$2B = peak normalization confirmed
• ◆AWM AUM growth (annual): AUM >$7.5T by end-2026 = structural compounder thesis confirmed

• ◆NII compression from Fed rate cuts (200bp scenario): MEDIUM-HIGH probability, HIGH severity; reduces NII from $103B to $87-95B, erases 1-2 years of earnings growth
• ◆Card NCO exceeds 4.5%: MEDIUM probability, HIGH severity; 1pp NCO increase adds ~$2B provision expense; hits both sides of earnings (credit + provision)
• ◆CIB markets normalization from Q1 2026 peak: HIGH probability, MEDIUM severity; $11.6B Q1 markets is cyclical high; Q2-Q4 likely revert to $8-9B run-rate
• ◆Basel III endgame capital surcharge reversion: LOW-MEDIUM probability, HIGH severity; >150bp RWA surcharge effectively freezes $50B buyback authorization
• ◆Lake transition disruption (key departures): LOW-MEDIUM probability, MEDIUM-HIGH severity; watch Pinto (retired), Lake/Erdoes/Piepszak stability through H2 2026
• ◆Stablecoin deposit disintermediation: LOW near-term, HIGH long-term (5-10 years); Kinexys/MONY could cannibalize core deposit franchise if CBDC bill passes
• ◆Geopolitical/tariff shock to M&A sentiment: MEDIUM probability, MEDIUM severity; dampens CIB advisory fee outlook and IB mandates